Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234336 · ClinicalTrials.gov registry record
Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 110
- Enrollment target
NCT02234336: Completed study, sponsored by Mayo Clinic.
NCT02234336 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02234336 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.
Interventions
- PROCEDURE Noncontrast echocardiography
- PROCEDURE Contrast Echocardiography
- PROCEDURE Cardiac magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02234336
The ClinicalTrials.gov registry entry for NCT02234336 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Noncontrast echocardiography is the first listed.
NCT02234336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02234336 about?
NCT02234336 is a clinical study titled "Assessment of Wall Thickness in Hypertrophic Cardiomyopathy". Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of ...
What is the current status of trial NCT02234336?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2014-10. Estimated completion is 2017-07-25.
What interventions are being tested in trial NCT02234336?
The interventions under investigation include: Noncontrast echocardiography (PROCEDURE), Contrast Echocardiography (PROCEDURE), Cardiac magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02234336?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.